{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:33:28Z","timestamp":1781217208994,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.nmd.2020.03.007","type":"journal-article","created":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T01:59:16Z","timestamp":1587002356000},"page":"389-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is it Pompe Disease? Australian diagnostic considerations"],"prefix":"10.1016","volume":"30","author":[{"given":"Michel","family":"Tchan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Kornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Kairaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Ellaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Reardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merrilee","family":"Needham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"McKelvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2020.03.007_bib0001","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","article-title":"Timing of diagnosis of patients with Pompe disease: data from the Pompe registry","volume":"161A","author":"Kishnani","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nmd.2020.03.007_bib0002","first-page":"78","article-title":"Early is better? a new algorithm for early diagnosis in late onset Pompe disease (LOPD)","volume":"32","author":"Toscano","year":"2013","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2020.03.007_bib0003","doi-asserted-by":"crossref","first-page":"A36","DOI":"10.1136\/jnnp-2018-ANZAN.89","article-title":"090\u2005The expanding clinical phenotype of late onset pompe disease: a multi-system disorder","volume":"89","author":"Reardon","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2020.03.007_bib0004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/mus.21393","article-title":"Diagnostic criteria for late-onset (childhood and adult) Pompe disease","volume":"40","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.03.007_bib0005","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1017\/cjn.2016.37","article-title":"Pompe disease: diagnosis and management. evidence-based guidelines from a Canadian expert panel","volume":"43","author":"Tarnopolsky","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.nmd.2020.03.007_bib0006","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1590\/0004-282X20150194","article-title":"Guidelines for the diagnosis, treatment and clinical monitoring of patients with juvenile and adult Pompe disease","volume":"74","author":"Llerena Junior","year":"2016","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.nmd.2020.03.007_bib0007","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s12883-015-0412-3","article-title":"Diagnosis and treatment of late-onset Pompe disease in the middle east and North Africa region: consensus recommendations from an expert group","volume":"15","author":"Al Jasmi","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nmd.2020.03.007_bib0008","first-page":"82","article-title":"Clinical features of Pompe disease","volume":"32","author":"Manganelli","year":"2013","journal-title":"Acta Myol"},{"key":"10.1016\/j.nmd.2020.03.007_bib0009","first-page":"200","article-title":"S1.3 adult-onset Pompe disease","volume":"30","author":"Di Iorio","year":"2011","journal-title":"Acta Myologica"},{"key":"10.1016\/j.nmd.2020.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/jpc.14070","article-title":"Infantile-onset Pompe disease: a case series highlighting early clinical features, spectrum of disease severity and treatment response","volume":"54","author":"Owens","year":"2018","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.nmd.2020.03.007_bib0011","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1750-1172-7-88","article-title":"Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study","volume":"7","author":"van der Beek","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2020.03.007_bib0012","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","article-title":"Pompe disease: a neuromuscular disease with respiratory muscle involvement","volume":"103","author":"Mellies","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.nmd.2020.03.007_bib0013","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2016.12.004","article-title":"The emerging phenotype of late-onset Pompe disease: a systematic literature review","volume":"120","author":"Chan","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.03.007_bib0014","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ajmg.c.31322","article-title":"Toward deconstructing the phenotype of late-onset Pompe disease","volume":"160C","author":"Schuller","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.nmd.2020.03.007_bib0015","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s10545-015-9825-9","article-title":"Skeletal muscle quantitative nuclear magnetic resonance imaging follow-up of adult Pompe patients","volume":"38","author":"Carlier","year":"2015","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.nmd.2020.03.007_bib0016","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/mus.25417","article-title":"Muscle MRI of classic infantile pompe patients: fatty substitution and edema-like changes","volume":"55","author":"Pichiecchio","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2020.03.007_bib0017","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.nmd.2016.09.001","article-title":"The frequency of late-onset Pompe disease in pediatric patients with limb-girdle muscle weakness and nonspecific hyperCKemia: a multicenter study","volume":"26","author":"Unver","year":"2016","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.03.007_bib0018","first-page":"5","article-title":"LOPED study: looking for an early diagnosis in a late-onset Pompe disease high-risk population","volume":"87","author":"Musumeci","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2020.03.007_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2015.04.008","article-title":"Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCKemia using dried blood: a Spanish cohort","volume":"25","author":"Gutierrez-Rivas","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.03.007_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.0000000000002758","article-title":"Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness","volume":"87","author":"Lukacs","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.03.007_bib0021","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2013.08.005","article-title":"Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies","volume":"110","author":"Preisler","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.03.007_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2013.03.002","article-title":"Screening for later-onset Pompe's disease in patients with paucisymptomatic hyperCKemia","volume":"109","author":"Spada","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.03.007_bib0023","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"10.1016\/j.nmd.2020.03.007_bib0024","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.03.007_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13023-019-1037-1","article-title":"Is early detection of late-onset Pompe disease a pneumologist's affair? a lesson from an Italian screening study","volume":"14","author":"Confalonieri","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2020.03.007_bib0026","doi-asserted-by":"crossref","first-page":"e00178","DOI":"10.1002\/rcr2.178","article-title":"Adult-onset Pompe's disease presenting with insidious hypercapnic respiratory failure","volume":"4","author":"O'Callaghan","year":"2016","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.nmd.2020.03.007_bib0027","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01214-2018","article-title":"ERS statement on respiratory muscle testing at rest and during exercise","author":"Laveneziana","year":"2019","journal-title":"Eur Resp J"},{"key":"10.1016\/j.nmd.2020.03.007_bib0028","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.03.007_bib0029","first-page":"199","article-title":"S1.2 the pediatrician and the early onset Pompe disease","volume":"30","author":"Fecarotta","year":"2011","journal-title":"Acta Myologica"},{"key":"10.1016\/j.nmd.2020.03.007_bib0030","unstructured":"Kemper A.R., Comeau A.M., Green N.S., Goldenberg A., Ojodu J., Prosser L.A., et al. on behalf of The Condition Review Workgroup. Evidence report: newborn screening for Pompe disease. Prepared for us health resources and services administration committee for the recommended uniform screening panel2013. [Accessed 26 Nov 2019] Available from:https:\/\/www.hrsa.gov\/sites\/default\/files\/hrsa\/advisory-committees\/heritable-disorders\/rusp\/previous-nominations\/pompe-external-evidence-review-report-2013.pdf"},{"key":"10.1016\/j.nmd.2020.03.007_bib0031","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1067\/mpd.2000.107112","article-title":"Identification of two subtypes of infantile acid maltase deficiency","volume":"137","author":"Slonim","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2020.03.007_bib0032","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.spen.2017.03.003","article-title":"Elevated creatine kinase in a 6-Year-Old boy","volume":"26","author":"Chan","year":"2018","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.nmd.2020.03.007_bib0033","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nmd.2007.06.002","article-title":"Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients","volume":"17","author":"Muller-Felber","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2020.03.007_bib0034","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe's disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2020.03.007_bib0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2007.09.006","article-title":"Methods for a prompt and reliable laboratory diagnosis of pompe disease: report from an international consensus meeting","volume":"93","author":"Winchester","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.03.007_bib0036","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1373\/clinchem.2016.269027","article-title":"Mass spectrometry but not fluorimetry distinguishes affected and pseudodeficiency patients in newborn screening for Pompe disease","volume":"63","author":"Liao","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.nmd.2020.03.007_bib0037","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.gim.0000204462.42910.b8","article-title":"Diagnostic challenges for Pompe disease: an under-recognized cause of floppy baby syndrome","volume":"8","author":"Howell","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2020.03.007_bib0038","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.03.007_bib0039","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1517\/17530050903460300","article-title":"Enzymatic and molecular strategies to diagnose Pompe disease","volume":"4","author":"Reuser","year":"2010","journal-title":"Expert Opin Med Diagn"},{"key":"10.1016\/j.nmd.2020.03.007_bib0040","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1373\/clinchem.2011.178319","article-title":"Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in Pompe disease and other glycogen storage diseases","volume":"58","author":"Sluiter","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.nmd.2020.03.007_bib0041","first-page":"67","article-title":"Baseline urinary glucose tetrasaccharide concentrations in patients with infantile- and late-onset Pompe disease identified by newborn screening","volume":"19","author":"Chien","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.nmd.2020.03.007_bib0042","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2005.03.010","article-title":"Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease","volume":"85","author":"An","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.03.007_bib0043","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/bbrc.1997.7811","article-title":"Mutation detection in glycogen storage-disease type II by RT-PCR and automated sequencing","volume":"241","author":"Hermans","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nmd.2020.03.007_bib0044","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.3390\/ijms13033245","article-title":"Use of the MLPA assay in the molecular diagnosis of gene copy number alterations in human genetic diseases","volume":"13","author":"Stuppia","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2020.03.007_bib0045","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/ajmg.a.38333","article-title":"Next generation deep sequencing corrects diagnostic pitfalls of traditional molecular approach in a patient with prenatal onset of Pompe disease","volume":"173","author":"Tsai","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nmd.2020.03.007_bib0046","first-page":"76","article-title":"Clinical laboratory experience of blood CRIM testing in infantile Pompe disease","volume":"5","author":"Bali","year":"2015","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.nmd.2020.03.007_bib0047","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/gim.2015.6","article-title":"CRIM-negative infantile Pompe disease: characterization of immune responses in patients treated with ERT monotherapy","volume":"17","author":"Berrier","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2020.03.007_bib0048","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1542\/peds.2016-0280D","article-title":"The initial evaluation of patients after positive newborn screening: recommended algorithms leading to a confirmed diagnosis of Pompe disease","volume":"140","author":"Burton","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2020.03.007_bib0049","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2012.04.013","article-title":"Algorithm for pompe disease newborn screening: results from the Taiwan screening program","volume":"106","author":"Chiang","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.03.007_bib0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijns4030023","article-title":"Newborn screening for lysosomal storage diseases: methodologies, screen positive rates, normalization of datasets, second-tier tests, and post-analysis tools","volume":"4","author":"Gelb","year":"2018","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"10.1016\/j.nmd.2020.03.007_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijns6010001","article-title":"Is newborn screening the ultimate strategy to reduce diagnostic delays in pompe disease? The parent and patient perspective","volume":"6","author":"Saich","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.nmd.2020.03.007_bib0052","doi-asserted-by":"crossref","DOI":"10.3390\/ijns4030021","article-title":"Newborn screening for lysosomal disease: mission creep and a taste of things to come?","volume":"4","author":"Wilcken","year":"2018","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.nmd.2020.03.007_bib0053","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1212\/WNL.0000000000004711","article-title":"Long-term benefit of enzyme replacement therapy in Pompe disease: a 5-year prospective study","volume":"89","author":"Kuperus","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2020.03.007_bib0054","article-title":"Using decision analysis to support newborn screening policy decisions: a case study for pompe disease","volume":"3","author":"Prosser","year":"2018","journal-title":"MDM Policy Pract"},{"key":"10.1016\/j.nmd.2020.03.007_bib0055","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/ene.13285","article-title":"European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10-year experience","volume":"24","author":"van der Ploeg","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2020.03.007_bib0056","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1542\/peds.2016-0280E","article-title":"Management of confirmed newborn-screened patients with Pompe disease across the disease spectrum","volume":"140","author":"Kronn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.nmd.2020.03.007_bib0057","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nmd.2019.11.007","article-title":"Discontinuation of enzyme replacement therapy in adults with Pompe disease: evaluating the European POmpe consortium stop criteria","volume":"30","author":"van Kooten","year":"2020","journal-title":"Neuromuscular Disorders"},{"key":"10.1016\/j.nmd.2020.03.007_bib0058","doi-asserted-by":"crossref","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.nmd.2020.03.007_bib0059","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2013.07.020","article-title":"The impact of informal care for patients with Pompe disease: an application of the Carerqol instrument","volume":"110","author":"Kanters","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.nmd.2020.03.007_bib0060","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.nmd.2020.03.007_bib0061","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-016-0442-y","article-title":"Childhood Pompe disease: clinical spectrum and genotype in 31 patients","volume":"11","author":"van Capelle","year":"2016","journal-title":"Orphanet J Rare Dis"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896620300845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:09:24Z","timestamp":1760774964000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896620300845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0960896620300845"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2020.03.007","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is it Pompe Disease? Australian diagnostic considerations","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2020.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}